EP Patent

EP0410348A1 — Topical spironolactone composition

Assigned to GD Searle LLC · Expires 1991-01-30 · 35y expired

What this patent protects

The invention relates to a topical spironolactone composition for the treatment of acne, hirsutism and other conditions caused by excess androgenic activity.

USPTO Abstract

The invention relates to a topical spironolactone composition for the treatment of acne, hirsutism and other conditions caused by excess androgenic activity.

Drugs covered by this patent

Patent Metadata

Patent number
EP0410348A1
Jurisdiction
EP
Classification
—
Expires
1991-01-30
Drug substance claim
No
Drug product claim
No
Assignee
GD Searle LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.